Docoh
Loading...

MDNA Medicenna Therapeutics

APP
Utility
INTERLEUKIN-2 Fusion Proteins and Uses Thereof
12 Aug 21
The present invention relates to interleukin-2 fusion proteins.
Fahar Merchant
Filed: 12 Aug 20
GRANT
Utility
Interleukin-4 receptor-binding fusion proteins and uses thereof
10 Aug 21
The present invention relates to interleukin-4 receptor binding fusion proteins.
Fahar Merchant, Raj K. Puri, Bharatkumar H. Joshi
Filed: 7 Sep 18
APP
Utility
Uses and Methods for Oncolytic Virus Targeting of IL-4/IL-13 and Fusions Thereof
5 Aug 21
The present invention provides an oncolytic virus vector containing a sequence encoding IL-4 receptor targeted cargo protein, including IL-4 muteins and/or IL-13 muteins, the oncolytic virus encoded therefrom, the uses of the oncolytic virus for treating cancer.
Fahar Merchant
Filed: 3 Jun 19
APP
Utility
IL-13/IL-4 Superkines: Immune Cell Targeting Constructs and Methods of Use Thereof
15 Jul 21
Methods and compositions are provided for enhancing anti-tumor effector immune cells with a targeting construct comprising a human IL-13 superkine and/or a human IL-4 superkine.
Kenan Christopher Garcia, Ignacio Moraga Gonzalez, Fahar Merchant
Filed: 3 Jun 19
APP
Utility
IL-4-FUSION Formulations for Treatment of Central Nervous System (CNS) Tumors
16 Dec 20
The present invention provides methods for the treatment of a central nervous system (CNS) tumor in a subject comprising administering and IL-4 targeted cargo protein formulated in an artificial cerebral spinal fluid formulation.
Fahar Merchant
Filed: 9 Oct 18
GRANT
Utility
Interleukin-2 fusion proteins and uses thereof
21 Sep 20
The present invention relates to interleukin-2 fusion proteins.
Fahar Merchant
Filed: 23 Sep 14
  • 1
Patents are sorted by USPTO publication date, most recent first